搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
lrmr
/
财务摘要
Larimar Therapeutics Inc
LRMR
添加自选
3.320
USD
-0.545
-14.10%
收盘 09-24 16:00(美东)
344.88M
总市值
亏损
市盈率 TTM
Larimar Therapeutics Inc
3.320
-0.545
-14.10%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
LRMR 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Larimar Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
344.88M
股息TTM
0.00
市盈率 TTM
-1.55
每股收益TTM
-2.14
营业收入
--
净利润
-80.60M
净资产收益率
-109.83%
总资产收益率
-87.67%
Larimar Therapeutics Inc 财报日历
最新发布
8月 4, 2026
每股收益 / 预测值
-0.32
/-0.38
营业收入 / 预测值
--
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
22.83%
-0.32
27.97%
-0.33
-62.21%
-0.73
-150.78%
-0.61
-20.64%
-0.41
-67.30%
-0.46
-52.61%
-0.45
-17.66%
-0.24
-77.86%
-0.34
-84.06%
-0.27
-38.46%
-0.30
--
-0.21
--
-0.19
--
-0.15
--
-0.21
--
-1.32
--
--
--
--
--
--
--
--
净利润
-25.21%
-32.78M
-1.13%
-29.61M
-116.83%
-62.50M
-207.84%
-47.71M
-21.06%
-26.18M
-99.82%
-29.28M
-121.84%
-28.82M
-71.00%
-15.50M
-158.51%
-21.63M
-124.55%
-14.65M
-37.86%
-12.99M
-8.94%
-9.06M
3.47%
-8.37M
27.03%
-6.53M
-3.19%
-9.43M
50.49%
-8.32M
31.26%
-8.67M
26.02%
-8.94M
35.69%
-9.13M
-63.57%
-16.80M
利润表
营业利润
-23.60%
-34.35M
0.23%
-31.12M
-104.58%
-64.02M
-171.02%
-49.50M
-12.98%
-27.79M
-86.38%
-31.19M
-120.96%
-31.29M
-76.65%
-18.26M
-155.71%
-24.60M
-119.12%
-16.73M
-35.66%
-14.16M
-21.45%
-10.34M
-10.74%
-9.62M
14.07%
-7.64M
-14.89%
-10.44M
49.12%
-8.51M
30.74%
-8.69M
26.59%
-8.89M
36.89%
-9.09M
-61.88%
-16.73M
净利润
-25.21%
-32.78M
-1.13%
-29.61M
-116.83%
-62.50M
-207.84%
-47.71M
-21.06%
-26.18M
-99.82%
-29.28M
-121.84%
-28.82M
-71.00%
-15.50M
-158.51%
-21.63M
-124.55%
-14.65M
-37.86%
-12.99M
-8.94%
-9.06M
3.47%
-8.37M
27.03%
-6.53M
-3.19%
-9.43M
50.49%
-8.32M
31.26%
-8.67M
26.02%
-8.94M
35.69%
-9.13M
-63.57%
-16.80M
资产负债表
流动资产
10.39%
160.67M
23.86%
204.98M
-27.28%
142.02M
-14.08%
183.22M
-37.02%
145.56M
-28.35%
165.49M
116.58%
195.30M
116.55%
213.26M
117.07%
231.13M
103.55%
230.95M
-25.31%
90.17M
-22.53%
98.48M
87.65%
106.48M
74.89%
113.46M
67.22%
120.74M
56.46%
127.13M
-23.36%
56.74M
-24.67%
64.88M
-26.29%
72.20M
-24.64%
81.25M
流动负债总额
28.21%
34.17M
115.76%
47.76M
166.03%
64.80M
177.04%
45.12M
25.97%
26.65M
72.37%
22.13M
156.22%
24.36M
148.32%
16.29M
190.79%
21.16M
60.31%
12.84M
-11.20%
9.51M
-30.38%
6.56M
-5.75%
7.28M
-9.73%
8.01M
21.02%
10.71M
-8.60%
9.42M
0.36%
7.72M
5.95%
8.87M
-1.62%
8.85M
99.03%
10.31M
总资产
10.21%
165.30M
22.53%
208.51M
-27.16%
145.84M
-14.46%
187.35M
-36.76%
149.99M
-31.44%
170.18M
108.71%
200.22M
110.69%
219.02M
112.29%
237.16M
108.74%
248.21M
-24.11%
95.94M
-21.85%
103.95M
77.74%
111.72M
66.95%
118.91M
60.68%
126.41M
51.26%
133.01M
-22.34%
62.85M
-23.43%
71.22M
-24.85%
78.67M
-22.83%
87.94M
总负债
25.84%
37.92M
94.87%
50.48M
138.47%
67.76M
134.29%
48.31M
16.99%
30.13M
49.21%
25.90M
99.88%
28.41M
83.46%
20.62M
118.55%
25.76M
37.07%
17.36M
-8.30%
14.21M
-21.69%
11.24M
-7.89%
11.79M
-10.28%
12.67M
8.76%
15.50M
-9.56%
14.35M
-4.55%
12.80M
-0.82%
14.12M
-4.94%
14.25M
40.25%
15.87M
总权益
6.28%
127.38M
9.54%
158.03M
-54.55%
78.08M
-29.92%
139.04M
-43.31%
119.85M
-37.50%
144.27M
110.24%
171.81M
114.00%
198.40M
111.55%
211.40M
117.28%
230.84M
-26.31%
81.72M
-21.87%
92.71M
99.64%
99.93M
86.05%
106.24M
72.17%
110.90M
64.66%
118.66M
-25.87%
50.06M
-27.52%
57.10M
-28.18%
64.41M
-29.79%
72.07M
现金流量表
经营净额
-127.18%
-44.03M
-68.10%
-44.61M
-76.61%
-38.53M
-17.14%
-28.75M
-38.55%
-19.38M
-154.92%
-26.54M
-133.49%
-21.82M
-166.80%
-24.55M
-89.93%
-13.99M
-37.88%
-10.41M
-40.03%
-9.34M
-56.52%
-9.20M
1.62%
-7.37M
-0.24%
-7.55M
15.74%
-6.67M
51.82%
-5.88M
30.57%
-7.49M
32.78%
-7.53M
19.67%
-7.92M
-8.71%
-12.20M
投资净额
-317.13%
-40.91M
100.72%
29.00M
77.11%
34.00M
21.07%
33.02M
129.68%
18.84M
121.13%
14.45M
830.20%
19.20M
158.74%
27.27M
-545.38%
-63.49M
-174.11%
-68.36M
94.97%
-2.63M
-1272.04%
-46.43M
72.16%
-9.84M
--
92.25M
-904.84%
-52.23M
50.17%
-3.38M
-283.89%
-35.34M
-100.00%
0.00
127.56%
6.49M
-84787.50%
-6.79M
融资净额
--
-435.00K
--
108.11M
-658.33%
-201.00K
217523.33%
65.29M
100.00%
0.00
-100.00%
0.00
--
36.00K
0.00%
30.00K
--
-334.00K
--
162.15M
100.00%
0.00
-99.96%
30.00K
--
--
--
0.00
--
-316.00K
280.05%
75.57M
--
0.00
--
0.00
-100.00%
0.00
14829.63%
19.89M
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Larimar Therapeutics Inc的流动资产是多少?
根据Larimar Therapeutics Inc的FY2025财报,流动资产为142.02M(同比变化-27.28)。
Larimar Therapeutics Inc的总资产是多少?
根据Larimar Therapeutics Inc的FY2025财报,Larimar Therapeutics Inc的总资产为145.84M(同比变化-27.16)。
Larimar Therapeutics Inc的总负债是多少?
根据Larimar Therapeutics Inc的FY2025财报,Larimar Therapeutics Inc的总负债为67.76M(同比变化138.47)。
Larimar Therapeutics Inc的总权益是多少?
根据Larimar Therapeutics Inc的FY2025财报,Larimar Therapeutics Inc的总权益为78.08M(同比变化-54.55)。
Larimar Therapeutics Inc的净营业收入是多少?
根据Larimar Therapeutics Inc的FY2025财报,Larimar Therapeutics Inc的净营业收入为-172.50M(同比变化-89.79)。
Larimar Therapeutics Inc的净投资是多少?
根据Larimar Therapeutics Inc的FY2025财报,Larimar Therapeutics Inc的净投资为100.31M(同比变化217.48)。
Larimar Therapeutics Inc的净融资是多少?
根据Larimar Therapeutics Inc的FY2025财报,Larimar Therapeutics Inc的净融资为65.09M(同比变化-59.79)。
Larimar Therapeutics Inc的每股收益(EPS)是多少?
根据Larimar Therapeutics Inc的FY2025财报,每股收益(EPS)为-2.27(同比变化-72.60)。
Larimar Therapeutics Inc的净利润是多少?
根据Larimar Therapeutics Inc的FY2025财报,净利润为-165.67M(同比变化-105.54)。
Larimar Therapeutics Inc的股东权益回报率(ROE)是多少?
根据Larimar Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-132.59(同比变化-108.53)。
Larimar Therapeutics Inc的资产回报率(ROA)是多少?
根据Larimar Therapeutics Inc的FY2025财报,资产回报率(ROA)为-95.75(同比变化-75.90)。
Larimar Therapeutics Inc的营业利润是多少?
根据Larimar Therapeutics Inc的FY2025财报,营业利润为-172.50M(同比变化-89.79)。